GYPA and atrial fibrillation: To note, there were no significant differences in circulating amount of CD235a+ PS+ RBC-derived vesicles between patients in entire cohort (370 ± 120 particles in μL and 420 ± 150 particles in μL, p = 0.24) and in non-AF subcohort (325 ± 70 particles in μL and 353 ± 80 particles in μL, p = 0.40) with HbA1c < 6.9% and HbA1c ≥ 7.0%, respectively.